Morling Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Morling Financial Advisors's LLY Position: Q2 2026 in Review
Morling Financial Advisors increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $3.06K and bringing the position to 236 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #62.
Morling Financial Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $468K in Q1 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Morling Financial Advisors held 236 shares of Eli Lilly worth $283K as of Q2 2026.
- Morling Financial Advisors bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
- Eli Lilly made up 0.08% of Morling Financial Advisors's portfolio in Q2 2026, its #62 holding.
- Morling Financial Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
- Morling Financial Advisors's Eli Lilly position peaked at $468K in Q1 2025.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Morling Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.